Compare ARK Genomic Revolution ETF (ARKG) vs Avient Corporation (AVNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Avient Corporation — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Avient Corporation trades at $45.51 (market cap $4.17B). The key difference: Avient Corporation pays a 2.42% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | AVNT | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $45.69 |
52-Week Low | $24.02 | $27.48 |
Market Cap | — | $4.17B |
Enterprise Value | — | $5.62B |
Dividend Yield | — | 2.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Avient Corporation
Avient Corporation is a global leader in specialized and sustainable material solutions. Formed from the legacy of PolyOne and Clariant’s masterbatch business, it provides highly engineered polymer formulations, color systems, and advanced composites that enhance the performance and sustainability of products in industries like healthcare, defense, and consumer packaging.
Read more on AVNT →
